Immunome (IMNM) Interest Coverage Ratio (2019 - 2020)
Immunome's (IMNM) quarterly Interest Coverage Ratio came in at 0.32 in Q1 2026, up 99.81% YoY from 0.16 in Q1 2025, and up 100.0% on a QoQ basis from 14572.2 in Q4 2025.
Analysis
Immunome (IMNM) Interest Coverage Ratio (2019 - 2020) Analysis & Trends
Immunome (IMNM) has 8 years of Interest Coverage Ratio data on file, last reported at 0.32 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 99.81% year-over-year to 0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.29 (up 99.57% YoY) and the FY2025 annual result came in at 1.24, up 56.71% from the prior year.
- Interest Coverage Ratio rose to 0.32 in Q1 2026, from 14572.2 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.32 in Q1 2026 to a low of 14572.2 in Q4 2025.
- A 5-year average of 1062.89 and a median of 4.96 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 5624.73% — and 2026, when it jumped 99.81%.
- Tracing IMNM's Interest Coverage Ratio over 5 years: stood at 26.67 in 2022, then slumped by 5624.73% to 1526.66 in 2023, then jumped by 81.88% to 276.57 in 2024, then slumped by 5168.96% to 14572.2 in 2025, then jumped by 100.0% to 0.32 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.32 (Q1 2026), 14572.2 (Q4 2025), and 1.44 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Immunome | 3.03 Bn | 2.51 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -0.51 |
| Dec 31, 2019 | -84.94 |
| Sep 30, 2019 | -160.00 |